• Affordable Care Act Forces Cardiology To Reveal Its Cholesterol Shell Game

    Posted August 12, 2013: by Bill Sardi

    Comment: The newly released report (click link to review), published in the Journal of the American Medical Association (JAMA), concedes that statin drugs have now been relegated as secondary intervention in the prevention of heart disease.  What now serves as primary prevention in its place, according to the JAMA report, are control of “lifestyle factors” such as smoking cessation, dietary measures, and limitation of alcohol intake).

    This is a nice way of saying the major direction of western medicine in the last forty years has been flawed, even corrupt.  Unfortunately, the only penalty for being wrong has been experienced by those who took statin drugs in good faith, paid the price with their lives, believing their well-trained physicians were guiding them in the right direction. That wasn’t true, and cardiologists knew this for a long time prior to the published report below.

    This report is not a mea culpa.  It tacitly says “we were wrong,” even though that simple admission is not forthcoming either.

    Between the lines it says modern medicine capitulated to Big Pharma as long as it filled their offices with patients and never got any of them well, so cardiology offices were perpetually booked with sick patients.

    It says modern medicine is immoral, self-serving, and unrepentantly arrogant as it insists its medicines are FDA-approved (yes) and evidenced-based (no they are not) compared to natural non-prescription remedies such as vitamin C, garlic, arginine, magnesium, thiamin, vitamin D3, vitamin K2, resveratrol and fish oil (which are not FDA approved but quite effective).

    If you are one of the 30 million statin drug users in the U.S., you need to read between the lines of the JAMA report, which is why I add my pointedly stinging criticism as a preface. Obviously, an MD’s version of this fiasco predictably clothes the failures of modern medicine in softer and undecipherable scientific terms. No one is held responsible.

    However, the Food & Drug Administration (FDA) gave license to all this misdirection by granting FDA approval based solely upon heart disease markers (cholesterol) rather than true decline in coronary artery disease mortality.  The FDA is complicit in this all-time ruse.

    Another admission is that statin drugs appear to be of statistical (but not clinical) benefit over the long term in regard to arterial calcification. But, but, cholesterol isn’t the culprit? Is this the long-awaited admission that arterial plaque is primarily composed of calcium not cholesterol?

    If so, modern medicine is down to one class of problematic drugs — calcium blockers. Meanwhile, nutritional medicine offers five de-calcifying agents: vitamin D3, vitamin K2, magnesium, IP6 phytate (rice bran) and L-arginine.

    What will Big Pharma do now? Will cardiologists finally stand up to the pharmaceutical makers?  Don’t hold your breath over that.  But the Affordable Care Act is forcing the issue – therapies must be evidence based, and this mandate is forcing modern medicine to reveal its shell game.

    This JAMA report says “alternative approaches for prevention of initial and recurrent vascular disease are being considered.” The report references a newly issued paper issued by the National Heart, Lung and Blood Institute (National Institutes of Health) which presents a “refocusing agenda on cardiovascular guidelines.”

    That NIH report, which does not spell out any details, saysHistory has taught us that there are very few immutable practices in science or medicine; and the time has come for a change in the National Heart Lung & Blood Institute practice of generating clinical guidelines.”

    Good God, are they really going to lose face, admit to 30 million statin drug users that cholesterol phobia has been a charade and millions have prematurely died as a result? I don’t think so.

    Big Pharma is unapologetic.  It is currently scheming to introduce yet another cholesterol controlling drug.  Is the FDA going to approve another heart drug based on markers rather than mortality?

    In the meantime, this reporter has issued an important bulletin that vindicates Drs. Linus Pauling and Matthias Rath and their discovery that vitamin C is required for incorporation into artery walls to prevent a circulating molecule, lipoprotein(a), from substituting in vitamin C’s place and weakening blood vessels.  Don’t tell me cardiology is ready to eat crow and begin using vitamin C?

    Nor should we overlook the landmark work of cardiologist Lester Morrison who showed in the early 1970s, prior to the era of the first statin drug (Mevacor), that the provision of supplemental chondroitin sulfate successfully treated many patients with unstable angina chest pain, eliminated the need for many medications and was shown in a small-scale study to dramatically reduce mortality from coronary artery disease.

    Both Drs. Pauling & Rath’s studies and Dr. Morrison’s work validate the collagen theory of artery disease.

    Meanwhile, humanity has been waiting eight years for a human clinical study to ensue since the red wine molecule resveratrol (rez-vair-ah-trol) was announced as a molecule that favorability switches genes and may mimic the heart health benefits observed among red wine drinkers.

    Where are the Wall Street Journal reporters on this important issue (protecting Big Pharma?)?  Where is the national news media?  Why isn’t the cardiology community being taken to task?  This isn’t about some trivial debate over the treatment of hemorrhoids or callouses, it’s about a life and death issue.  A major redirection is announced (though lacking details) over a month ago, and not a word about it in the news press, at least not yet.  ©2013 Bill Sardi, Knowledge of Health, Inc.

    Share

Leave a Reply

You must be logged in to post a comment.